BioSpace News Archive

Today, at the Advances in Genome Biology and Technology (AGBT) 2021 General Meeting held virtually, BioSkryb, Inc., a developer of genomic amplification technologies, announced the winners of a research grant program sponsored by the company.

Eurofins Environment Testing America has become the only commercial environmental laboratory to have the capability of reporting up to 75 PFAS target analytes, 70 from a single injection in potable and non-potable water.

Impel NeuroPharma, a late-stage pharmaceutical company focused on utilizing our proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, today announced the appointments of Leonard S. Paolillo as chief commercial officer and Gerald F. Penn as vice president, market access and trade

Medidata, a Dassault Systèmes company, announced its participation at the 12th Annual Summit for Clinical Ops Executives (SCOPE)

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company developing cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C and Alzheimer’s Disease, today announced the appointment of Gerald F. Cox, MD, PhD as Acting Chief Medical Officer.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Jordan Pinsker, MD, to Vice President and Medical Director, effective April 26, 2021.

PPJ Enterprise (OTC PINK:PPJE), a leader in Healthcare Reimbursement Cycle Expert for Complex Medical/Surgical Services and proprietary Automated Healthcare Practice Management Software, online Health Information Digital Systems and Medical Practice Information Management, is pleased to announce new business of two doctors group and the company will start processing their billing on 4/15/2021 and just hired a nationally well known digital marketing company

Hillrom (NYSE: HRC) today provided an update on its planned acquisition of Bardy Diagnostics, Inc. (BardyDx), which it previously announced on January 19, 2021.

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Quidel QuickVue At-Home COVID-19 Test, another antigen test where certain individuals can rapidly collect and test their sample at home, without needing to send a sample to a laboratory for analysis.

Grand River Aseptic Manufacturing (“GRAM”), a leading parenteral contract development and manufacturing organization (“CDMO”), congratulates Johnson & Johnson on receiving emergency use authorization from the Food and Drug Administration (“FDA”) for its single-shot COVID-19 vaccine